These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L. Proc Natl Acad Sci U S A; 1997 May 27; 94(11):5667-72. PubMed ID: 9159130 [Abstract] [Full Text] [Related]
45. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Theodoropoulos VE, Lazaris ACh, Sofras F, Gerzelis I, Tsoukala V, Ghikonti I, Manikas K, Kastriotis I. Eur Urol; 2004 Aug 27; 46(2):200-8. PubMed ID: 15245814 [Abstract] [Full Text] [Related]
46. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer. Ping W, Jiang WY, Chen WS, Sun W, Fu XN. Asian Pac J Cancer Prev; 2013 Aug 27; 14(6):3613-8. PubMed ID: 23886154 [Abstract] [Full Text] [Related]
48. Siah-1 is associated with expression of hypoxia-inducible factor-1α in oral squamous cell carcinoma. Aga M, Kondo S, Wakisaka N, Moriyama-Kita M, Endo K, Nakanishi Y, Murono S, Sugimoto H, Ueno T, Yoshizaki T. Auris Nasus Larynx; 2017 Apr 27; 44(2):213-219. PubMed ID: 27616748 [Abstract] [Full Text] [Related]
51. Cardiac expressions of HIF-1 alpha and HLF/EPAS, two basic loop helix/PAS domain transcription factors involved in adaptative responses to hypoxic stresses. Ladoux A, Frelin C. Biochem Biophys Res Commun; 1997 Nov 26; 240(3):552-6. PubMed ID: 9398602 [Abstract] [Full Text] [Related]
52. Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Burri P, Djonov V, Aebersold DM, Lindel K, Studer U, Altermatt HJ, Mazzucchelli L, Greiner RH, Gruber G. Int J Radiat Oncol Biol Phys; 2003 Jun 01; 56(2):494-501. PubMed ID: 12738326 [Abstract] [Full Text] [Related]
53. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms. Zhong H, Willard M, Simons J. Int J Cancer; 2004 Nov 20; 112(4):585-95. PubMed ID: 15382039 [Abstract] [Full Text] [Related]
57. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma. Zhao X, Tang YP, Wang CY, Wu JX, Ye F. Eur Rev Med Pharmacol Sci; 2019 Apr 20; 23(8):3351-3357. PubMed ID: 31081089 [Abstract] [Full Text] [Related]
58. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Clin Cancer Res; 2001 Jun 20; 7(6):1661-8. PubMed ID: 11410504 [Abstract] [Full Text] [Related]
59. A meta-analysis of HIF-1α and esophageal squamous cell carcinoma (ESCC) risk. Sun G, Hu W, Lu Y, Wang Y. Pathol Oncol Res; 2013 Oct 20; 19(4):685-93. PubMed ID: 23658132 [Abstract] [Full Text] [Related]
60. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Rajakumar A, Brandon HM, Daftary A, Ness R, Conrad KP. Placenta; 2004 Nov 20; 25(10):763-9. PubMed ID: 15451190 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]